Vikes, Dance Fever, French Fries. The names might not be familiar to you, but chances are good your kids have heard of them. These are the street names for prescription drugs, and more and more teens are using them to get high.
Each year, nearly 2 million teens abuse prescription drugs. The new parent’s Prescription and Over-the-Counter Drug Guide from BeSmartBeWell.com and The Partnership at Drugfree.org breaks down the most commonly abused prescription and over-the-counter drugs in a simple-to-understand and interactive web page. Learn drugs’ “street” names, how kids are using them (inject, inhale, etc.), why they're dangerous and the warning signs of abuse.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/besmartbewell/50821/
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s antibacterial drug DIFICID™ (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. CDAD is a significant medical problem in hospitals and long-term care facilities, and is beginning to emerge in the community among people previously at low risk for the disease. In the largest Phase 3 clinical studies ever conducted in CDAD, DIFICID had clinical response rates at the end of treatment that were non-inferior to oral vancomycin. DIFICID was superior to vancomycin in sustaining clinical response through 25 days beyond the end of treatment. DIFICID is the only FDA-approved antibacterial drug proven to be superior to vancomycin in sustained clinical response for CDAD.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/optimerpharma/50177/
As soon as you start feeling run down or have other flu-like symptoms, take Oscillococcinum.
Oscillo® is supported by published clinical studies, as well as more than 65 years of use throughout the world.
-Clinical studies show that Oscillo reduces the severity and duration of flu-like symptoms such as headache, body aches, chills and fever
-Great taste and convenient to take
-No side effects; no drug interactions; non-drowsy
-Safe for everyone 2 years of age and older
To view Multimedia News Release, go to http://www.multivu.com/players/English/45775-Boiron-Oscillococcinum/
Gen-Probe (NASDAQ: GPRO) announced today the US Food and Drug Administration (FDA) has approved its PROGENSA® PCA3 (Prostate Cancer gene 3) assay, the first molecular test to help determine the need for repeat prostate biopsies in men who have had a previous negative biopsy.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53530-gen-probe-progensa-pca3-prostate-cancer-psa
James Palumbo\'s fantastical debut novel is a brilliant riposte to the financial crisis now engulfing us. Like Candide and Gulliver before him, Tomas will startle your imagination, yet linger in your mind. For what seems grotesque, even impossible, has already happened...
A dark, troubling animation that comes across like a horrid drug trip into the shallowness of wealth... http://www.tomas-book.com
The University of Texas Health Science Center at Houston (UTHealth) has begun enrollment for the first Phase I safety study approved by the Food and Drug Administration to investigate the use of a child’s own umbilical cord blood stem cells for traumatic brain injury in children. The study is being performed in conjunction with Children’s Memorial Hermann Hospital, UTHealth’s primary children’s teaching hospital.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/cordblood/48021/
Boston Scientific Corporation (NYSE: BSX) announces positive clinical data from the Research in Severe Asthma (RISA) Trial, demonstrating the long-term safety of bronchial thermoplasty (BT) in patients treated with the Company’s AlairTM Bronchial Thermoplasty System. Follow-up data demonstrate that stable lung function is maintained and late clinical complications are absent over a five-year period in patients with severe refractory asthma treated with BT. Results were presented today at the annual European Respiratory Society (ERS) Congress in Amsterdam by Michel Laviolette, M.D., Professor of Medicine, Institut universitaire de cardiologie et de pneumologie at Université Laval in Québec City, Canada.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/bostonscientific/52128/
http://www.youtube.com/watch?v=9pxuBgfbid0 blu electronic cigarette commercial - blu electronic cigarettes have no ash and no offensive odor, so I can enjoy them anywhere. In my car, at work, at my favorite restaurant or even at my friends house. Four different strengths mean I can control my nicotine intake and it cost less than regular cigarettes. blu is the smarter alternative to cigarettes and the best way to take back you're freedom. blu is available at many fine retailers including, Sheetz, Ingles, Kerr Drug, Harps, Cumberland Farms, H-E-B, Scolari's and Couche-Tard.
A page turning, timely novel that perfectly captures the anxieties of plunging into the criminal underworld and the zeitgeist of the recession generation, Mule is about young people trying to make do in a moment when the American Dream they never had to believe in, because it was handed to them, fully wrapped and ready to go at the take out window, suddenly vanished from the menu. Learn more about this book here, http://bit.ly/o7MZ3v and its author here, http://www.tonydsouza.com/ fiction
Drugs are everywhere. The use of prescription painkillers has increased dramatically in recent years, and prescription drug abuse is now the nation’s fastest-growing drug problem. According to the U.S. Department of Health and Human Services, more than 5 million Americans misuse painkillers each month. Opioid painkillers—a class of very powerful and potentially addicting pain relievers—are the most common source of drug overdose deaths, resulting in more unintentional deaths than cocaine and heroin combined.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prescriptiondrugabuse/50825/
The Ad Council is joining the U.S. Department of Agriculture’s Food Safety and Inspection Service, in partnership with the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), to debut their first joint national multimedia public service campaign to help families prevent food poisoning in the home.
The Food Safe Families campaign was announced this morning by USDA Secretary Tom Vilsack and HHS Secretary Kathleen Sebelius in time for the July 4th holiday and the start of summer when foodborne illnesses tend to increase—a time when many families celebrate with food. It’s also a time when foodborne illnesses tend to increase with more outdoor meals, and other factors that increase the risk for disease-causing bacteria in food.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/adcouncil/50582/
